Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Cardiovascular Risk Factors from Early Life Predict Future Adult Cardiac Structural and Functional Abnormalities: A Systematic Review of the Published Literature.

Journal of cardiology and therapeutics

Ghosh AK, Francis DP, Chaturvedi N, Kuh D, Mayet J, Hughes AD, Hardy RJ.
PMID: 27294103
J Cardiol Ther. 2014 Jul;2(2):78-87. doi: 10.12970/2311-052X.2014.02.02.4.

BACKGROUND: Clinical practice evaluates cardiovascular risk based on current risk factor (RF) levels [Blood pressure (BP), body mass index (BMI) and glycaemic control] largely disregarding previous risk-factor history over the totality of the life course. RFs are related to...

Cannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice.

Journal of cardiology and therapeutics

Netherland-Van Dyke C, Rodgers W, Fulmer M, Lahr Z, Thewke D.
PMID: 26413498
J Cardiol Ther. 2015 Jul;3(2):53-63. doi: 10.12970/2311-052X.2015.03.02.2.

PURPOSE: WIN55,212-2, a potent synthetic agonist of cannabinoid receptor type 1 (CB1) and cannabinoid receptor type 2 (CB2), reduces atherosclerosis in apolipoprotein E (ApoE) null mice. Although pharmacologic evidence suggests the anti-atherosclerotic effects of WIN55,212-2 are mediated METHODS: After...

Showing 1 to 2 of 2 entries